📷 Image: Wikimedia Commons / Yann (talk)
Health
Rajasthan cracks down on IVF centre over blue‑fetus advertisement
✍️ The Hindu
🗓 26 Aug 2026, 01:44 PM
👁 2
Regulatory authorities in Rajasthan have initiated action against an IVF centre after a promotional ad featuring a blue‑coloured foetus drew public criticism.
The state health department in Rajasthan has opened an inquiry into an IVF clinic that aired a television advertisement showing a blue‑coloured foetus. The ad, intended to highlight the clinic's advanced reproductive technologies, sparked outrage on social media for its unconventional visual portrayal.
Officials say the advertisement may violate advertising standards that prohibit misleading or sensational content in medical promotions. A notice has been issued to the clinic to withdraw the ad and provide a detailed explanation of the scientific basis, if any, for using the blue imagery.
The clinic has not yet responded publicly, but the department has warned that further non‑compliance could lead to penalties, including suspension of its operating licence. The case underscores growing scrutiny of medical advertising in India, especially in the fertility sector.
Consumer groups have called for stricter oversight to ensure that prospective patients receive accurate information about IVF procedures and outcomes. The investigation remains ongoing, with the health department promising a final report within the next few weeks.
Officials say the advertisement may violate advertising standards that prohibit misleading or sensational content in medical promotions. A notice has been issued to the clinic to withdraw the ad and provide a detailed explanation of the scientific basis, if any, for using the blue imagery.
The clinic has not yet responded publicly, but the department has warned that further non‑compliance could lead to penalties, including suspension of its operating licence. The case underscores growing scrutiny of medical advertising in India, especially in the fertility sector.
Consumer groups have called for stricter oversight to ensure that prospective patients receive accurate information about IVF procedures and outcomes. The investigation remains ongoing, with the health department promising a final report within the next few weeks.